Cariprazine Completed Phase 1 Trials for Schizophrenic Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01376076Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia